SCHEMBL3602189

SCHEMBL3602189

Cc1ccc2c(c1)ncn2CC(=O)NCCNCC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CASP1 P29466 1/20 0.43
TP53 P04637 4/20 0.42
TRPA1 O75762 1/20 0.42
ALDH1A1 P00352 4/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 2/20 0.41
NAMPT P43490 1/20 0.40
MAPT P10636 2/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599702 0.92 GRIN2B (0.41) HPGDMEN1KMT2ATP53TRPA1
SCHEMBL5345354 0.92 TRPA1 (0.44) HPGDMEN1KMT2ATP53TRPA1
SCHEMBL3597093 0.88 BACE1 (0.47) HPGDMEN1KMT2ATRPA1ALDH1A1
SCHEMBL3606208 0.87 TP53 (0.44) HPGDMEN1KMT2ATP53ALDH1A1
SCHEMBL3605823 0.83 HTT (0.42) HPGDMEN1KMT2AALDH1A1RAB9A
SCHEMBL3602186 0.82 TP53 (0.41) HPGDMEN1KMT2ACASP1TP53
SCHEMBL5367271 0.81 MTNR1A (0.53) HPGDKMT2ATP53ALDH1A1HSD17B10
SCHEMBL3594719 0.78 RXFP1 (0.42) HPGDKMT2ATP53TRPA1ALDH1A1
SCHEMBL3608393 0.78 PRPS1 (0.41) HPGDMEN1KMT2ATP53TRPA1
SCHEMBL3597269 0.77 ENPP2 (0.45) HPGDMEN1KMT2ATP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 HPGD 3386/4885MEN1 4362/4885KMT2A 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.